Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16114 | 28559541 | Int J Obes (Lond) | Adiponectin deficiency rescues high-fat diet-induced hepatic injury, apoptosis and autophagy loss despite persistent steatosis. | 2017 | Details |
| A16120 | 28554682 | Clin Gastroenterol Hepatol | Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. | 2017 | Details |
| A16124 | 28550439 | Obes Surg | Baseline Anthropometric and Metabolic Parameters Correlate with Weight Loss in Women 1-Year After Laparoscopic Roux-En-Y Gastric Bypass. | 2017 | Details |
| A16126 | 28550272 | J Biomed Res | Non-alcoholic fatty liver disease--a chronic disease of the 21<sup>st</sup> century. | 2018 | Details |
| A16127 | 28549912 | Exp Cell Res | Fatty liver and FGF21 physiology. | 2017 | Details |
| A16129 | 28549240 | J Nutr Biochem | Dietary salecan reverts partially the metabolic gene expressions and NMR-based metabolomic profiles from high-fat-diet-induced obese rats. | 2017 | Details |
| A16131 | 28546081 | Pharmacol Ther | Targeting nuclear receptors for the treatment of fatty liver disease. | 2017 | Details |
| A16136 | 28544608 | Obes Rev | Screening for non-alcoholic fatty liver disease in children: do guidelines provide enough guidance? | 2017 | Details |
| A16137 | 28544258 | Liver Int | Incidence and risk factors for non-alcoholic fatty liver disease: A 7-year follow-up study among urban, adult Sri Lankans. | 2017 | Details |
| A16138 | 28544245 | Diabetes Obes Metab | Ghrelin receptor inverse agonists as a novel therapeutic approach against obesity-related metabolic disease. | 2017 | Details |
| A16139 | 28544208 | Liver Int | Ultra-high-field magnetic resonance spectroscopy in non-alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non-alcoholic steatohepatitis and advanced fibrosis. | 2017 | Details |
| A16141 | 28542544 | PLoS One | Development and characterization of an experimental model of diet-induced metabolic syndrome in rabbit. | 2017 | Details |
| A16149 | 28537562 | Pol Przegl Chir | Impact of bariatric surgery on non-alcoholic fatty liver disease. | 2017 | Details |
| A16154 | 28534852 | Nutrients | Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies. | 2017 | Details |
| A16158 | 28533304 | J Lipid Res | Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids. | 2017 | Details |
| A16160 | 28533219 | Mol Cell Biol | Obesity-Linked Phosphorylation of SIRT1 by Casein Kinase 2 Inhibits Its Nuclear Localization and Promotes Fatty Liver. | 2017 | Details |
| A16161 | 28529818 | J Diabetes Metab | High protein/fish oil diet prevents hepatic steatosis in NONcNZO10 mice; association with diet/genetics-regulated micro-RNAs. | 2016 | Details |
| A16165 | 28528267 | HPB (Oxford) | Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. | 2017 | Details |
| A16169 | 28526925 | Eur J Nutr | Polyphenolic extract attenuates fatty acid-induced steatosis and oxidative stress in hepatic and endothelial cells. | 2017 | Details |
| A16171 | 28525362 | Horm Mol Biol Clin Investig | FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases. | 2017 | Details |
| A16172 | 28524171 | Nat Rev Endocrinol | Endocrine-disrupting chemicals and fatty liver disease. | 2017 | Details |
| A16174 | 28521872 | Metabolism | Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. | 2017 | Details |
| A16175 | 28521870 | Metabolism | The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. | 2017 | Details |
| A16177 | 28521680 | Curr Med Chem | Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis. | 2019 | Details |
| A16178 | 28520503 | Metab Syndr Relat Disord | Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014. | 2017 | Details |
| A16185 | 28512251 | Mol Cancer Res | Inhibition of the Cell Death Pathway in Nonalcoholic Steatohepatitis (NASH)-Related Hepatocarcinogenesis Is Associated with Histone H4 lysine 16 Deacetylation. | 2017 | Details |
| A16186 | 28511733 | Nutr Res Rev | Similarities and interactions between the ageing process and high chronic intake of added sugars. | 2017 | Details |
| A16188 | 28511199 | Inflamm Bowel Dis | Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease. | 2017 | Details |
| A16189 | 28511168 | Wiad Lek | [The nonalcoholic steatohepatitis influence on the course and progression of ischemic heart disease]. | 2017 | Details |
| A16190 | 28511163 | Wiad Lek | [Impact of physical activity on anthropometric indices in patients with nonalcoholic fatty liver disease and pre-diabetes or type 2 diabetes]. | 2017 | Details |
| A16191 | 28511161 | Wiad Lek | [The diagnostics and clinical pattern of nonalcoholic fatty liver disease in patients with pre-diabetes and type 2 diabetes and obesity]. | 2017 | Details |
| A16195 | 28510581 | PLoS One | Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study. | 2017 | Details |
| A16197 | 28508477 | Hepatology | The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance. | 2017 | Details |
| A16198 | 28508194 | Endocrine | Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals. | 2017 | Details |
| A16209 | 28506362 | Gastroenterol Clin North Am | Current Concepts in Pediatric Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16212 | 28505074 | Nutrients | NAFLD and Atherosclerosis Are Prevented by a Natural Dietary Supplement Containing Curcumin, Silymarin, Guggul, Chlorogenic Acid and Inulin in Mice Fed a High-Fat Diet. | 2017 | Details |
| A16213 | 28504910 | J Med Food | Fermented Moringa oleifera Decreases Hepatic Adiposity and Ameliorates Glucose Intolerance in High-Fat Diet-Induced Obese Mice. | 2017 | Details |
| A16216 | 28503750 | Diabetes Obes Metab | Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial. | 2017 | Details |
| A16222 | 28502444 | Pediatr Clin North Am | Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications. | 2017 | Details |
| A16224 | 28501537 | Clin Gastroenterol Hepatol | Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers. | 2017 | Details |
| A16231 | 28496045 | J Atheroscler Thromb | Cholic Acid Enhances Visceral Adiposity, Atherosclerosis and Nonalcoholic Fatty Liver Disease in Microminipigs. | 2017 | Details |
| A16233 | 28494548 | Zhonghua Gan Zang Bing Za Zhi | [The role of cytochrome P450 in nonalcoholic fatty liver induced by high-fat diet: a gene expression profile analysis]. | 2017 | Details |
| A16237 | 28492501 | Nutrients | Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations. | 2017 | Details |
| A16244 | 28487551 | Int J Obes (Lond) | High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance. | 2017 | Details |
| A16247 | 28484247 | Sci Rep | Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota. | 2017 | Details |
| A16258 | 28481662 | Metab Syndr Relat Disord | The Correlation Between Body Fat, Visceral Fat, and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16267 | 28478385 | J Biol Chem | Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism. | 2017 | Details |
| A16270 | 28475023 | Acta Radiol | Acoustic radiation force impulse imaging for detection of liver fibrosis in overweight and obese children. | 2017 | Details |
| A16273 | 28473066 | J Am Coll Radiol | ACR Appropriateness Criteria® Chronic Liver Disease. | 2017 | Details |
| A16275 | 28472948 | BMC Gastroenterol | Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter. | 2017 | Details |
| A16282 | 28471828 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease can be predicted by retinal vascular changes in patients with obesity without hypertension or diabetes. | 2017 | Details |
| A16292 | 28469809 | World J Hepatol | Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. | 2017 | Details |
| A16299 | 28469090 | JCI Insight | Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis. | 2017 | Details |
| A16300 | 28468951 | Clin Sci (Lond) | Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease. | 2017 | Details |
| A16301 | 28468933 | J Endocrinol | The metabolic syndrome in mice overexpressing neuropeptide Y in noradrenergic neurons. | 2017 | Details |
| A16303 | 28468017 | Dig Dis | Lessons from Epidemiology: The Burden of Liver Disease. | 2017 | Details |
| A16310 | 28465298 | J Am Heart Assoc | Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study. | 2017 | Details |
| A16312 | 28464369 | Aliment Pharmacol Ther | Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. | 2017 | Details |
| A16315 | 28463404 | Mol Nutr Food Res | A synbiotic composed of Lactobacillus fermentum CECT5716 and FOS prevents the development of fatty acid liver and glycemic alterations in rats fed a high fructose diet associated with changes in the microbiota. | 2017 | Details |
| A16316 | 28462811 | Trends Endocrinol Metab | Sphingolipids and Lipoproteins in Health and Metabolic Disorders. | 2017 | Details |
| A16319 | 28461774 | Korean J Physiol Pharmacol | Endogenous catalase delays high-fat diet-induced liver injury in mice. | 2017 | Details |
| A16320 | 28461687 | Int J Obes (Lond) | Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease. | 2017 | Details |
| A16321 | 28460349 | Cancer Epidemiol | Nonalcoholic fatty liver disease and mortality among cancer survivors. | 2017 | Details |
| A16322 | 28460180 | Can J Physiol Pharmacol | Role of folate in nonalcoholic fatty liver disease. | 2017 | Details |
| A16329 | 28457061 | Isr Med Assoc J | Association between Fatty Liver Disease and Hyperplastic Colonic Polyp. | 2017 | Details |
| A16330 | 28456640 | Arch Biochem Biophys | Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease. | 2017 | Details |
| A16331 | 28455679 | Curr Obes Rep | Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over. | 2017 | Details |
| A16335 | 28452429 | Obesity (Silver Spring) | Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model. | 2017 | Details |
| A16340 | 28448433 | Int J Environ Res Public Health | Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese Children. | 2017 | Details |
| A16342 | 28446519 | Diabetes | Cationic Polystyrene Resolves Nonalcoholic Steatohepatitis, Obesity, and Metabolic Disorders by Promoting Eubiosis of Gut Microbiota and Decreasing Endotoxemia. | 2017 | Details |
| A16343 | 28446162 | BMC Pediatr | Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity. | 2017 | Details |
| A16345 | 28445310 | Medicine (Baltimore) | Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy. | 2017 | Details |
| A16347 | 28445156 | Oncotarget | Dietary capsaicin and antibiotics act synergistically to reduce non-alcoholic fatty liver disease induced by high fat diet in mice. | 2017 | Details |
| A16348 | 28443804 | J Am Coll Nutr | 25(OH)D Levels in Relation to Gender, Overweight, Insulin Resistance, and Inflammation in a Cross-Sectional Cohort of Northern Italian Workers: Evidence in Support of Preventive Health Care Programs. | 2017 | Details |
| A16351 | 28442522 | Ann Clin Lab Sci | Clinical Criteria Correlated with the Incidence of Patients with Non-alcoholic Fatty Liver Disease. | 2017 | Details |
| A16352 | 28442507 | J Endocrinol | Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice. | 2017 | Details |
| A16356 | 28441459 | PLoS One | Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study. | 2017 | Details |
| A16357 | 28441156 | Curr Opin Lipidol | Interpreting lipoproteins in nonalcoholic fatty liver disease. | 2017 | Details |
| A16364 | 28436456 | Sci Rep | Synthesis and anti-obesity effects in vivo of Crotadihydrofuran C as a novel PPARγ antagonist from Crotalaria albida. | 2017 | Details |
| A16370 | 28432400 | Internist (Berl) | [The intestinal microbiome and metabolic diseases : From obesity to diabetes and nonalcoholic steatohepatitis]. | 2017 | Details |
| A16374 | 28429344 | Eur Rev Med Pharmacol Sci | Up-regulation of microRNA-367 promotes liver steatosis through repressing TBL1 in obese mice. | 2017 | Details |
| A16375 | 28429199 | Curr Gastroenterol Rep | Gastric Bypass and Influence on Improvement of NAFLD. | 2017 | Details |
| A16376 | 28428634 | Nat Rev Gastroenterol Hepatol | Lipid droplets and liver disease: from basic biology to clinical implications. | 2017 | Details |
| A16377 | 28428362 | J Endocrinol | Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones. | 2017 | Details |
| A16379 | 28427239 | Oncotarget | Foxo3a-dependent Bim transcription protects mice from a high fat diet via inhibition of activation of the NLRP3 inflammasome by facilitating autophagy flux in Kupffer cells. | 2017 | Details |
| A16380 | 28426902 | Liver Transpl | Hepatic steatosis after pediatric liver transplant. | 2017 | Details |
| A16388 | 28424263 | J Biol Chem | The kielin/chordin-like protein (KCP) attenuates high-fat diet-induced obesity and metabolic syndrome in mice. | 2017 | Details |
| A16389 | 28422962 | PLoS One | Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice. | 2017 | Details |
| A16390 | 28422749 | JCI Insight | Obesity-induced hepatic steatosis is mediated by endoplasmic reticulum stress in the subfornical organ of the brain. | 2017 | Details |
| A16393 | 28420164 | Int J Mol Sci | The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function. | 2017 | Details |
| A16394 | 28420094 | Nutrients | Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments. | 2017 | Details |
| A16405 | 28414763 | PLoS One | Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations. | 2017 | Details |
| A16406 | 28414138 | Biochem Pharmacol | Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation. | 2017 | Details |
| A16409 | 28412824 | Arch Iran Med | Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study. | 2017 | Details |
| A16410 | 28411553 | Biomed Pharmacother | Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats. | 2017 | Details |
| A16412 | 28411170 | Biochim Biophys Acta Biomembr | The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. | 2017 | Details |
| A16423 | 28402022 | J Cell Biochem | Steroidogenic Acute Regulatory Protein (StAR) Overexpression Reduces Inflammation and Insulin Resistance in Obese Mice. | 2017 | Details |
| A16426 | 28397375 | Clin Obes | Elevation of circulating microRNA levels in obese children compared to healthy controls. | 2017 | Details |
| A16428 | 28395890 | Am J Cardiol | Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans. | 2017 | Details |
| A16433 | 28392404 | Prog Lipid Res | A global perspective on FOXO1 in lipid metabolism and lipid-related diseases. | 2017 | Details |